Despite Setbacks, PhRMA Awards Encourage Research into and Fight against Alzheimer's

Delaying the onset of AD by just five years could reduce the cost for care of Alzheimer's patients by $447 billion a year by 2050, according to a new PhRMA report.
Sep 13, 2012